2027 Addiction Toxicology Case Conference Webinar Series – Full Year Registration Package
-
Register
- Non-member - Tier I - Free!
- Non-member - Tier II - Free!
- Non-member - Tier III - Free!
- Non-member - Tier IV - Free!
- Member - Tier I - Free!
- Member - Tier II - Free!
- Member - Tier III - Free!
- Member - Tier IV - Free!
2027 ACMT Addiction Toxicology Case Conference Webinar Series
Register for the entire year with just one easy click!
Typically held every month on Fridays at 1 pm ET, these webinars bring together experts in addiction medicine, psychiatry, and medical toxicology to analyze real-world addiction toxicology cases, providing valuable insights and fostering dynamic discussions through live Q&A sessions. Here’s what we've got on the calendar for 2027:
- January 8, 2027 - Topic To Be Announced
- February 5, 2027- Topic To Be Announced
- March 5, 2027 - Topic To Be Announced
- April - CANCELLED
- May 7, 2027 - Topic To Be Announced
- June 4, 2027 - Topic To Be Announced
- July - CANCELLED
- August 6, 2027 - Topic To Be Announced
- September 3, 2027 - Topic To Be Announced
- October 1, 2027 - Topic To Be Announced
- November 5, 2027 - Topic To Be Announced
- December 3, 2027 - Topic To Be Announced
About The Series: The ACMT Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
These webinars are open to the public.
-
Contains 4 Component(s) Includes a Live Web Event on 01/08/2027 at 1:00 PM (EST)
Topic To be Announced
Topic To be Announced
Friday, January 8, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 02/05/2027 at 1:00 PM (EST)
Topic To be Announced
Topic To be Announced
Friday, February 5, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 03/05/2027 at 1:00 PM (EST)
Topic To be Announced
Topic To be Announced
Friday, March 5, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 05/07/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, May 7, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 06/04/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, June 4, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 08/06/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, August 6, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 09/03/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, September 3, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 10/01/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, October 1, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 11/05/2027 at 1:00 PM (EDT)
Topic To be Announced
Topic To be Announced
Friday, November 5, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.
-
Contains 4 Component(s) Includes a Live Web Event on 12/03/2027 at 1:00 PM (EST)
Topic To be Announced
Topic To be Announced
Friday, December 3, 2027
1:00-2:00pm ETCases to be announced!
Learning Objectives
1. Learning Objectives to be Announced!
About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.
This webinar is free and open to the public.
$i++ ?>Timothy J. Wiegand, MD, FACMT, DFASAM (Moderator)
Director and CEO, Toxicology Consulting
Medicine, Addiction Toxicology Consulting PLLC, ASAM President Elect (2025-2027)
Dr. Tim Wiegand is the Director of Toxicology Consults and President of CMO Medicine and Toxicology & Addiction Consulting. Board-certified in both Medical Toxicology and Addiction Medicine, Dr. Wiegand specializes in Addiction Toxicology, combining clinical practice with research, teaching, and leadership roles. He has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and is currently on the Board of Directors for the American Society of Addiction Medicine (ASAM). From 2023-2025, he served as Treasurer of ASAM, having previously served as Vice President on the Executive Council. From 2025-2027, Dr. Wiegand will serve as ASAM President Elect and then ASAM President (2027-2029). Dr. Wiegand founded and led the Toxicology Service at URMC until 2022, when he transitioned to Director of Addiction Medicine and Director of Addiction Medicine Consults in the Department of Emergency Medicine. He also serves as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and is leading efforts to launch the URMC Medical Toxicology Fellowship, which is expected to be formally accredited by July 2023.